Publications Print Morecroft RA, Phillipps JS, Gou L, Bhatt AA, Kim S, Mohammadi H, Dronca RS, Doonan B, Chen R, Zhao Y, Kang HS, Li S, Janus JR, Pirgousis P, Patel S, Okuyemi OT, Singer EM, Tolaymat LM, Wysong A, Degesys CA, Barbosa N, Holtzman AL. Immunotherapy and Radiation for Clinical Perineural Invasion in Cutaneous Squamous Cell Carcinoma. Cancers (Basel). 2025 Dec 8; 17 (24) Epub 2025 Dec 08 View PubMed Carrera-Justiz S, Aghaee M, Qdaisat S, Weidert F, Garcia GA, Fagman L, Zhang D, Stover B, Moor RSF, Xie C, Goldenberg E, von Roemeling C, Doonan B, Chardon-Robles J, Elliott L, Sawyer WG, Deleyrolle LP, Sahay B, Foster TP, Seligson ND, Rahman M, Ghiaseddin A, Castillo P, Lee JH, Silver NL, Doty A, Ligon JA, Milner RJ, Mitchell D, Mendez-Gomez H, Moore H, Sayour EJ. Systemic mRNA vaccines elicit rapid immune activation in canine brain tumors. J Immunother Cancer. 2025 Nov 11; 13 (11) View PubMed Winer ES, Konopleva M, Tun HW, Lim KH, Doonan B, Metzeler KH, Nayak L, Ferreri AJM, von Roemeling C, Nowakowski GS, Garcia-Manero G. Meeting Report From the 2024 Symposium on IRAK4 in Cancer: Highlights and Clinical Updates. Clin Lymphoma Myeloma Leuk. 2025 Nov; 25 (11):e924-e932 Epub 2025 May 30 View PubMed Rao A, Mathavan A, Mathavan A, Doonan B. A comprehensive review and case series of adjuvant and neoadjuvant therapies in acral melanoma with emerging insights from ct dna testing. Frontiers in Oncology. 2025 Oct 14; 15:1619248 von Roemeling CA, Patel JA, Carpenter SL, Yegorov O, Yang C, Bhatia A, Doonan BP, Russell R, Trivedi VS, Klippel K, Ryu DH, Grippin A, Futch HS, Ran Y, Hoang-Minh LB, Weidert FL, Golde TE, Mitchell DA. Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade. Nat Commun. 2024 Jul 12; 15 (1):5871 Epub 2024 July 12 View PubMed Trivedi V, Yang C, Klippel K, Yegorov O, von Roemeling C, Hoang-Minh L, Fenton G, Ogando-Rivas E, Castillo P, Moore G, Long-James K, Dyson K, Doonan B, Flores C, Mitchell DA. mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors. Genome Med. 2024 Jan 25; 16 (1):17 View PubMed McGrath K, Elliott T, Archibald V, Matich E, Galochkina Z, Lee J, Doonan B. Absence of Tils in Biopsy is Associated with Worse Progression Free Survival in Early Stage Melanoma. Journal of Clinical and Medical Surgery. 2024; 4. Von Roemeling CA, Doonan BP, Klippel K, Schultz D, Hoang-Minh L, Trivedi V, Li C, Russell RA, Kanumuri RS, Sharma A, Tun HW, Mitchell DA. Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases. Clin Cancer Res. 2023 May 1; 29 (9):1751-1762 View PubMed Doonan BP, Amria S, Bethard JR, Banik NL, Hathaway-Schrader JD, Haque A. Peptide Modification Diminishes HLA Class II-restricted CD4(+) T Cell Recognition of Prostate Cancer Cells. Int J Mol Sci. 2022 Dec 3; 23 (23) Epub 2022 Dec 03 View PubMed Ali A, Bosse RC, Doonan BP, Narayan P, Jester GA, Delaune JD, Barish JL, Welniak SL, Norton HF, Heldermon CD. Ommaya Reservoir Related Complications: A Single Center Experience and Review of Current Literature. International Journal of Clinical Oncology and Cancer Research. 2019; 4(2):10-24. Hathaway-Schrader JD, Doonan BP, Hossain A, Radwan FFY, Zhang L, Haque A. Autophagy-dependent crosstalk between GILT and PAX-3 influences radiation sensitivity of human melanoma cells. J Cell Biochem. 2018 Feb; 119 (2):2212-2221 Epub 2017 Oct 18 View PubMed Doonan BP, Ohnuma K, Dang L, Morimoto C, Dang N. Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target. Current Cancer Therapy Reviews. 2017; 13(2):76-88. Doonan BP, Haque A. Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design. J Clin Cell Immunol. 2015 Aug; 6 (4) Epub 2015 Aug 26 View PubMed Hossain A, Radwan FF, Doonan BP, God JM, Zhang L, Bell PD, Haque A. A possible cross-talk between autophagy and apoptosis in generating an immune response in melanoma. Apoptosis. 2012 Oct; 17 (10):1066-78 View PubMed Radwan FF, Zhang L, Hossain A, Doonan BP, God JM, Haque A. Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol. Leuk Lymphoma. 2012 Feb; 53 (2):305-14 Epub 2011 Oct 24 View PubMed Smith AW, Doonan BP, Tyor WR, Abou-Fayssal N, Haque A, Banik NL. Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients. J Neuroimmunol. 2011 Mar; 232 (1-2):179-85 Epub 2010 Nov 13 View PubMed DaPalma T, Doonan BP, Trager NM, Kasman LM. A systematic approach to virus-virus interactions. Virus Res. 2010 Apr; 149 (1):1-9 Epub 2010 Jan 20 View PubMed Johnson BM, Doonan BP, Radwan FF, Haque A. Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer. Open Prost Cancer J. 2010 Jan 1; 3:78-85 View PubMed Doonan BP, Haque A. HLA Class II Antigen Presentation in Prostate Cancer Cells: A Novel Approach to Prostate Tumor Immunotherapy. Open Cancer Immunol J. 2010 Jan 1; 3:1-7 View PubMed PST-20586681 Home Publications